Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    HIV AND "treatment naive" | Open Studies | HIV
Show Display Options
Rank Status Study
21 Recruiting Oral Human Papillomavirus Infection in HIV-infected Men
Conditions: Papillomavirus Infections;   HIV Infections
Intervention: Procedure: Oral swabs for HPV-typing and high-risk HPV-determination
22 Recruiting A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects
Condition: Immunodeficiency Virus Type 1, Human
Interventions: Drug: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC;   Drug: DRV/COBI FDC;   Drug: FTC/TDF FDC;   Drug: D/C/F/TAF FDC - Matching Placebo;   Drug: FTC/TDF FDC Matching Placebo;   Drug: DRV/COBI FDC Matching Placebo
23 Recruiting Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients
Condition: HIV
Intervention:
24 Recruiting Resistance in HIV+ in North and South
Condition: HIV Drug Resistance
Intervention:
25 Not yet recruiting An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens in Aged HIV Patients (RalAge)
Condition: HIV
Intervention: Other: Observational retrospective cohort to describe RAL data
26 Unknown  A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
Condition: HIV Infections
Intervention: Drug: Kaletra and Intelence Tablets
27 Recruiting Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals
Condition: HIV Infection
Intervention: Drug: Polyphenon E
28 Recruiting A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Intervention: Drug: ABT-493/ABT-530
29 Unknown  Pediatric Nevirapine Resistance Study
Conditions: AIDS;   HIV Infections
Intervention: Drug: nevirapine
30 Unknown  Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)
Condition: HIV Infection
Intervention: Drug: mycophenol mofetil (MMF, Cellcept®) 500 mg BID
31 Not yet recruiting Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Initial ARV Therapy
Condition: HIV
Intervention: Device: Digital Health Feedback System
32 Recruiting Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events
Condition: HIV-Infection
Intervention: Other: Time of starting antiretroviral therapy
33 Unknown  To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients
Conditions: Evaluated;   Non B Subtype;   Naive Patients
Intervention:
34 Recruiting Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial
Condition: HIV
Intervention: Drug: alendronate/vitamin D
35 Recruiting A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista
Condition: Acquired Immune Deficiency Syndrome
Intervention: Drug: No intervention
36 Recruiting Intensive Models of HCV Care for Injection Drug Users
Conditions: Hepatitis C;   Medication Adherence
Intervention: Other: Intensive Models (mDOT and CGT) of HCV Care

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years